• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinicopathological Characteristics and Overall 5-Year Survival of Colorectal Cancer: A Retrospective Study.结直肠癌的临床病理特征及总体 5 年生存率:一项回顾性研究。
Med Sci (Basel). 2022 Aug 9;10(3):42. doi: 10.3390/medsci10030042.
2
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.结直肠癌中癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)血清水平预后价值的多变量分析
Anticancer Res. 2000 Nov-Dec;20(6D):5195-8.
3
Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.循环肿瘤细胞,包括肿瘤干细胞样细胞,在外周血中的临床意义与 Dukes'B 和 C 期结直肠癌患者的复发和预后相关。
J Clin Oncol. 2011 Apr 20;29(12):1547-55. doi: 10.1200/JCO.2010.30.5151. Epub 2011 Mar 21.
4
Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients.肿瘤引流静脉血循环肿瘤细胞和干细胞对 Dukes'B 和 C 期结直肠癌患者预后的意义。
Oncol Rep. 2012 Apr;27(4):947-53. doi: 10.3892/or.2012.1649. Epub 2012 Jan 19.
5
Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.微小RNA-21作为生物标志物在结直肠癌各Dukes分期中的临床意义。
Oncol Rep. 2015 Feb;33(2):573-82. doi: 10.3892/or.2014.3614. Epub 2014 Nov 21.
6
Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.日本根治性淋巴结清扫术对Dukes' B期和C期结直肠癌患者10年生存率的改善:一项17年的回顾性研究。
Oncol Rep. 2003 Jul-Aug;10(4):927-34.
7
For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.对于患有杜克B期(TNM分期II期)结直肠癌的患者,检查六个或更少的淋巴结与预后不良有关。
Cancer. 1998 Aug 15;83(4):666-72.
8
Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.结直肠癌患者术前血清癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)水平及其预后意义
Anticancer Res. 1997 Jul-Aug;17(4B):2935-8.
9
Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.PDCD4 表达的预后意义及其与结直肠癌各 Dukes 分期患者中 microRNA-21 的关系。
Oncol Rep. 2012 May;27(5):1384-92. doi: 10.3892/or.2012.1648. Epub 2012 Jan 19.
10
Different distribution of Dukes' stage between proximal and distal colorectal cancer.近端和远端结直肠癌之间Dukes分期的不同分布。
Hepatogastroenterology. 2002 Nov-Dec;49(48):1535-7.

引用本文的文献

1
Enhanced diagnostic accuracy of SINE-EUS compared to standard EUS in early colorectal cancer: a self-controlled study.与标准超声内镜相比,短链脂肪酸增强超声内镜在早期结直肠癌诊断中的准确性提高:一项自身对照研究。
Int J Colorectal Dis. 2025 Feb 1;40(1):30. doi: 10.1007/s00384-025-04814-z.
2
Comprehensive analysis of cuproptosis-related genes involved in prognosis and tumor microenvironment infiltration of colorectal cancer.与铜死亡相关基因在结直肠癌预后及肿瘤微环境浸润中的综合分析
Transl Cancer Res. 2024 Sep 30;13(9):4555-4573. doi: 10.21037/tcr-24-546. Epub 2024 Sep 27.
3
The Biological Behavior and Clinical Application Prospects of Deoxythymidine Kinase Gene in Tumors.肿瘤中脱氧胸苷激酶基因的生物学行为及临床应用前景。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241265396. doi: 10.1177/15330338241265396.
4
PLK3 is linked with higher tumor stage and unfavorable prognosis in patients with colorectal cancer.PLK3 与结直肠癌患者的较高肿瘤分期和不良预后相关。
Biomark Med. 2024;18(6):221-230. doi: 10.2217/bmm-2023-0591. Epub 2024 Apr 17.

本文引用的文献

1
Colorectal cancer patients in western Saudi Arabia. Outcomes and predictors for survival over a 10-years period (2002-2014).沙特阿拉伯西部的结直肠癌患者。10年期间(2002 - 2014年)的生存结果及预测因素
Saudi Med J. 2019 Dec;40(12):1227-1234. doi: 10.15537/smj.2019.12.24699.
2
Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors.结直肠癌的流行病学:发病率、死亡率、生存率及危险因素。
Prz Gastroenterol. 2019;14(2):89-103. doi: 10.5114/pg.2018.81072. Epub 2019 Jan 6.
3
Body Mass Index and Long-Term Outcomes in Patients With Colorectal Cancer.体重指数与结直肠癌患者的长期预后
Front Oncol. 2018 Dec 17;8:620. doi: 10.3389/fonc.2018.00620. eCollection 2018.
4
Trends in the incidence and mortality of cancer in Saudi Arabia.沙特阿拉伯癌症的发病率和死亡率趋势。
Saudi Med J. 2018 Dec;39(12):1259-1262. doi: 10.15537/smj.2018.12.23348.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
Colorectal cancer: A looming threat, opportunities, and challenges for the Saudi population and its healthcare system.结直肠癌:对沙特人口及其医疗保健系统而言,是一个迫在眉睫的威胁、机遇与挑战。
Saudi J Gastroenterol. 2018 May-Jun;24(3):196-197. doi: 10.4103/sjg.SJG_164_18.
7
Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.二甲双胍使用与接受根治性切除的非转移性直肠癌患者生存之间的关联:一项全国性人群研究。
Cancer Res Treat. 2017 Jan;49(1):29-36. doi: 10.4143/crt.2016.128. Epub 2016 Jul 4.
8
Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies.沙特阿拉伯的结直肠癌:发病率、生存率、人口统计学及对国家政策的影响。
Ann Saudi Med. 2015 May-Jun;35(3):196-202. doi: 10.5144/0256-4947.2015.196.
9
Metformin use and survival after colorectal cancer: A population-based cohort study.二甲双胍的使用与结直肠癌患者的生存情况:一项基于人群的队列研究。
Int J Cancer. 2016 Jan 15;138(2):369-79. doi: 10.1002/ijc.29720. Epub 2015 Aug 31.
10
Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?如果相互调整,二甲双胍、他汀类药物和阿司匹林的使用与糖尿病结直肠癌患者的总死亡率是否仍有关联?
Br J Cancer. 2015 Jul 28;113(3):403-10. doi: 10.1038/bjc.2015.259. Epub 2015 Jul 16.

结直肠癌的临床病理特征及总体 5 年生存率:一项回顾性研究。

Clinicopathological Characteristics and Overall 5-Year Survival of Colorectal Cancer: A Retrospective Study.

机构信息

Department of Surgery, Faculty of Medicine, King Abdulaziz University, Jeddah 22254, Saudi Arabia.

出版信息

Med Sci (Basel). 2022 Aug 9;10(3):42. doi: 10.3390/medsci10030042.

DOI:10.3390/medsci10030042
PMID:35997334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9396983/
Abstract

Colorectal cancer (CRC) is the third leading cause of cancer-related death. We aimed to investigate the clinicopathological characteristics and 5-year survival in CRC. This retrospective study reviewed King Abdulaziz University Hospital records from 2009 to 2019. Tumor staging was performed using Dukes’ pathological classification. Additionally, we measured the frequency of qualitative data and performed the chi-square and Mann−Whitney U-tests. Kaplan−Meier analysis was performed to calculate overall survival. Of the 574 included patients (age (mean ± standard deviation), 55.51 ± 14.28 years), 43.2% were Saudis, and most were male (58.7%). The rectum was the most common location of CRC (30.8%); 33.1% of patients presented with abdominal pain. The dominant histological variant was mucinous adenocarcinoma (95.5%). Age at diagnosis was significantly associated with Dukes’ staging; 36.3% of individuals aged <50 years had Dukes’ D stage. The 5-year survival rate was 47.9%. Better survival was noted for those of Saudi nationality, those with Dukes’ A stage, and those who were overweight (51.6%, 56.3%, and 46.8%, respectively). Significantly better survival was seen in Saudi patients due to accessible healthcare and in overweight patients due to better treatment tolerance. The outcome of CRC was not related to sex or metformin use in patients with diabetes mellitus.

摘要

结直肠癌(CRC)是癌症相关死亡的第三大主要原因。我们旨在研究 CRC 的临床病理特征和 5 年生存率。这项回顾性研究回顾了 2009 年至 2019 年阿卜杜勒阿齐兹国王大学医院的记录。肿瘤分期采用 Dukes 病理分类进行。此外,我们还测量了定性数据的频率,并进行了卡方和曼-惠特尼 U 检验。采用 Kaplan-Meier 分析计算总生存率。在纳入的 574 例患者中(年龄(均值±标准差),55.51±14.28 岁),43.2%为沙特人,大多数为男性(58.7%)。CRC 最常见的部位是直肠(30.8%);33.1%的患者出现腹痛。主要的组织学变异型是黏液性腺癌(95.5%)。诊断时的年龄与 Dukes 分期显著相关;36.3%的<50 岁患者处于 Dukes D 期。5 年生存率为 47.9%。沙特国籍、Dukes A 期和超重患者的生存情况更好(分别为 51.6%、56.3%和 46.8%)。沙特患者由于获得了可及的医疗保健,超重患者由于更好的治疗耐受性,生存情况明显更好。CRC 的结果与糖尿病患者的性别或二甲双胍的使用无关。